ACE and renal tubular dysgenesis of genetic origin: We have established iPSCs from an AR-RTD patient harboring a biallelic pathogenic variant in the ACE gene23, and we used CRISPR to genetically disrupt ACE and AGTR1 genes in a human iPSC line isolated from a healthy donor.